Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Prenetics Global Ltd
PRECurrent price
4.88 USD
+0.39 USD (+8.69%)
1Y
3Y
5Y
10Y
15Y
PRE
Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes multi-cancer early detection technologies. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests. Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. Additionally, it is involved in the sports distribution activities providing sports nutrition products to fitness facilities. The company operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States. Address: Unit 703-706, K11 Atelier King?s Road, Quarry Bay, Hong Kong
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9 USDP/E ratio
–Dividend Yield
–Current Year
+21 742 675 USD
Last Year
+275 761 298 USD
Current Quarter
+5 941 532 USD
Last Quarter
+6 413 397 USD
Current Year
+8 829 887 USD
Last Year
+131 554 886 USD
Current Quarter
+3 768 272 USD
Last Quarter
+3 782 646 USD
Key Figures PRE
1 year
3 years
5 years
10 years
EBITDA
-36 695 144 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-10.31 %
PEG Ratio
–
Return On Equity TTM
-21.67 %
Wall Street Target Price
9 USD
Revenue TTM
22 662 330 USD
Book Value
15.4 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
4.3 %
Dividend Yield
–
Gross Profit TTM
131 554 886 USD
Earnings per share
-3.47 USD
Diluted Eps TTM
-3.47 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-219.78 %
Dividend Analytics PRE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PRE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
14.11.2023
Dividend Date
–
Stock Valuation PRE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.2853
Price Sales TTM
2.4798
Enterprise Value EBITDA
0.1429
Price Book MRQ
0.2985
Financials PRE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PRE
For 52 weeks
2.85 USD
6.99 USD
50 Day MA
4.52 USD
Shares Short Prior Month
31 244
200 Day MA
5.03 USD
Short Ratio
1.34
Shares Short
32 295
Short Percent
0.33 %
BeatStart